Table 3.

Negative attributes associated with oral administration reported by patients with cancer

Attribute	Description of attribute	Study sample
Time required to stand upright15	Refers to oral bisphosphonate treatment, where patients must remain upright for at least 30 minutes to limit epigastric pain	Patients with metastatic breast cancer being treated for bone metastases with bisphosphonates
Inability to eat or drink15	Refers to oral bisphosphonate treatment, which must be taken in the morning on an empty stomach; patients reporting wanting to drink or eat beforehand as a reason for non-adherence	Patients with metastatic breast cancer being treated for bone metastases with bisphosphonates
Forgetfulness8	Easy to forget to take oral medication	Patients with a primary diagnosis of lymphoma, breast, colorectal, gynecologic, lung, or other cancer